Cargando…

Relationship of urinary isoprostanes to prostate cancer occurence

To estimate the oxidative stress in patients with prostate cancer and in a control group, we used the biomarker of lipid peroxidation–isoprostanes (8-isoPGF(2)) and the level of selected antioxidants (glucose and uric acid [UA]). The level of urinary isoprostanes was determined in patients and contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brys, Magdalena, Morel, Agnieszka, Forma, Ewa, Krzeslak, Anna, Wilkosz, Jacek, Rozanski, Waldemar, Olas, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506833/ https://www.ncbi.nlm.nih.gov/pubmed/22983829 http://dx.doi.org/10.1007/s11010-012-1455-z

Ejemplares similares

Urine markers and prostate cancer
por: Wilkosz, Jacek, et al.
Publicado: (2011)

Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer
por: Krześlak, Anna, et al.
Publicado: (2012)

HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies – after photodynamic diagnosis (PDD)
por: Markowski, Michał, et al.
Publicado: (2012)

Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer
por: Forma, Ewa, et al.
Publicado: (2013)

Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance—promising for molecular staging of prostate cancers
por: Bryś, Magdalena, et al.
Publicado: (2013)

Rate of positive urine culture and double–J catheters colonization on the basis of microorganism DNA analysis
por: Kliś, Rafał, et al.
Publicado: (2014)

The calpain system as a potential target for pelvic muscle reinforcement
por: Blewniewski, Mariusz, et al.
Publicado: (2011)

O-GlcNAcylation and Metabolic Reprograming in Cancer
por: Jóźwiak, Paweł, et al.
Publicado: (2014)

The potential role of O-GlcNAc modification in cancer epigenetics
por: Forma, Ewa, et al.
Publicado: (2014)

Effect of metformin on apoptosis induction in ovarian cancer cells
por: Rogalska, Aneta, et al.
Publicado: (2014)

Gene expression of O-GlcNAc cycling enzymes in human breast cancers
por: Krześlak, Anna, et al.
Publicado: (2011)

Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2015)

RAD51 and XRCC3 Polymorphisms Are Associated with Increased Risk of Prostate Cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2019)

Expression of TopBP1 in hereditary breast cancer
por: Forma, Ewa, et al.
Publicado: (2012)

Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
por: Forma, Ewa, et al.
Publicado: (2018)

Relationship between polycomb‐group protein BMI‐1 and phosphatases regulating AKT phosphorylation level in endometrial cancer
por: Zaczek, Agnieszka, et al.
Publicado: (2019)

Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
por: Starska, Katarzyna, et al.
Publicado: (2014)

Topoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endometrial Cancer Risk
por: Forma, Ewa, et al.
Publicado: (2013)

Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer
por: Nowacka-Zawisza, Maria, et al.
Publicado: (2015)

Complication rates after prostate biopsy according to the number of sampled cores
por: Madej, Adam, et al.
Publicado: (2012)

The correlation of crystalline and elemental composition of urinary stones with a history of bacterial infections: TXRF, XRPD and PCR-DGGE studies
por: Arabski, Michał, et al.
Publicado: (2018)

Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions
por: Jóźwiak, Paweł, et al.
Publicado: (2017)

Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer
por: Starska, Katarzyna, et al.
Publicado: (2014)

Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
por: Krzeslak, Anna, et al.
Publicado: (2012)

Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
por: Miller, Elżbieta, et al.
Publicado: (2014)

Evaluation of hemostasis parameters and the role of the oxidative damage to plasma proteins in the modulation of hemostasis in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy
por: Woźniak, Paweł, et al.
Publicado: (2017)

Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents
por: Olas, Beata, et al.
Publicado: (2020)

Novel Findings regarding the Bioactivity of the Natural Blue Pigment Genipin in Human Diseases
por: Bryś, Magdalena, et al.
Publicado: (2022)

Anticancer Activity of Propolis and Its Compounds
por: Forma, Ewa, et al.
Publicado: (2021)

Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)
por: Starska, Katarzyna, et al.
Publicado: (2015)

Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
por: Rogalska, Aneta, et al.
Publicado: (2018)

Oxidative Stress and Hemostatic Parameters in Patients With Nephrolithiasis Before and After Ureteroscopic Lithotripsy
por: Woźniak, Paweł, et al.
Publicado: (2019)

Analysis of Long Non-Coding RNA (lncRNA) uc.38 and uc.63 Expression in Breast Carcinoma Patients
por: Zadrożna-Nowak, Anna, et al.
Publicado: (2022)

Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation
por: Il'yasova, Dora, et al.
Publicado: (2015)

TET3- and OGT-Dependent Expression of Genes Involved in Epithelial-Mesenchymal Transition in Endometrial Cancer
por: Ciesielski, Piotr, et al.
Publicado: (2021)

Urinary 15-F(2t)-Isoprostane Concentrations in Dogs with Liver Disease
por: Phillips, Robert Kyle, et al.
Publicado: (2023)

Comparison of the Results of Therapy for cT1 Renal Carcinoma with Nephron-Sparing Surgery (NSS) vs. Percutaneous Thermal Ablation (TA)
por: Rusinek, Michał, et al.
Publicado: (2022)

Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?
por: Ting, Harold J, et al.
Publicado: (2010)

Isoprostanes-Biomarkers of Lipid Peroxidation: Their Utility in Evaluating Oxidative Stress and Analysis
por: Janicka, Monika, et al.
Publicado: (2010)

Urinary F(2)-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
por: Il'yasova, Dora, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ob16amlh92lcq253rh5n5l8tg1